Drugs that contain Formoterol Fumarate; Glycopyrrolate

1. Drug name - BEVESPI AEROSPHERE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8324266 ASTRAZENECA Compositions, methods and systems for respiratory delivery of two or more active agents May, 2030

(7 years from now)

US10716753 ASTRAZENECA Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems May, 2030

(7 years from now)

US9415009 ASTRAZENECA Compositions, methods and systems for respiratory delivery of two or more active agents May, 2030

(7 years from now)

US8703806 ASTRAZENECA Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents May, 2030

(7 years from now)

US8808713 ASTRAZENECA Compositions for pulmonary delivery of long-acting β2 adrenergic receptor agonists and associated methods and systems May, 2030

(7 years from now)

US9463161 ASTRAZENECA Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems May, 2030

(7 years from now)

US8815258 ASTRAZENECA Compositions, methods and systems for respiratory delivery of two or more active agents Mar, 2031

(8 years from now)

Treatment: Use for the maintenance treatment of patients with chronic obstructive pulmonary disease (copd)

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
0.0048MG/INH;0.0090MG/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.